VANGUARD RESEARCH GROUP
Mark your calendar for
our August 31st
webinar on the
Concept of Clinical
If you missed our past
webinars, you can
find them here:
THE ROLE OF TECHNOLOGY IN BEHAVIORAL HEALTH
Over the last decades, technology has become an integral part of behavioral
health care and the COVID-19 pandemic accelerated the development with its
shift to telemedicine. Whether in the area of data collection, accessing care,
employing innovating treatment options – there is a multitude of possibilities
and also challenges. Review below article for an overview:
VRG has been involved in the development and execution of a number of
behavioral health studies involving a range of technology and behavioral health
apps. The “Improving Care, Reducing Cost” (ICRC) study for example provided a
treatment program for recently discharged schizophrenia patients and included
an app on cognitive behavioral treatment for paranoia and voices, a digital family
support program and technology-based decision assistant for psychiatrists to
support pharmacological treatment. Find a recent publication on the program
attached to this newsletter and an invitation to participate in our upcoming
technology-based studies below!
VRG INVITES YOU TO JOIN OUR NEW FUTURE STUDIES AND PROJECTS
A NOVEL PHARMACOLOGICAL TREATMENT FOR ACUTE AGITATION IN SCHIZOPHRENIA / BIPOLAR DISORDER
FOR USE IN CRISIS STABILIZATION UNITS / PSYCH ER.
A NOVEL PHARMACOLOGICAL TREATMENT FOR ACUTE SUICIDAL IDEATION IN BIPOLAR DISORDER FOR USE IN
CRISIS STABILIZATION UNITS / PSYCH ER.
TESTING A NEW THERAPY APP PROVIDING TREATMENT FOR MDD
SMARTPHONE-BASED MEASURING OF BIOMARKERS SUCH AS HEART AND RESPIRATION RATE
DON’T FORGET: WE ALSO INVITE YOU TO CONTACT US WITH YOUR QUALITY IMPROVEMENT PROJECTS FOR CONSUTLATION AND SUPPORT
If you are interested in learning more or participating, please email Marta Hauser at email@example.com.
FOLLOW US ON SOCIAL MEDIA
VANGUARD RESEARCH GROUP
WEBINAR SERIES 2022
ALL WEBINARS ARE HELD 12-1PM EST
HOW CMHCS CAN PARTICIPATE IN RESEARCH AND WHY IT IS IMPORTANT FOR CLINICAL PRACTICE (PRESENTER: DR. MARTA HAUSER)
An introduction to different aspects and benefits of conducting research at an agency like yours. What clinical and policy implications have resulted from previous research at CMHCs, how research can be implemented within your agency, and how can we support you in becoming part of the research community.
RESEARCH 101 (SESSION 1) – PRACTICAL INTRODUCTION TO RESEARCH IN THE CLINIC (PRESENTER: DR. MARTA HAUSER)
Familiarizing your clinic with a variety of concepts and aspects of research: Institutional Review Boards, Good Clinical Practice, Subject Protection, Safety Reporting and more
RESEARCH 101 (SESSION 2) – STUDY PROTOCOL AND INFORMED CONSENT (PRESENTER DR. MARTA HAUSER)
Details on the two cornerstones of any study: The study protocol and informed consent
INTRODUCTION TO THE CONCEPT OF CLINICAL HIGH-RISK OF PSYCHOSIS (PRESENTER DR. MARTA HAUSER)
Signs and symptoms, assessment scales and current practice
PROTOCOL DEVIATIONS AND CAPAS (CORRECTIVE AND PREVENTATIVE ACTION PLAN) (PRESENTER CRISTINA GONZALEZ)
What counts as a protocol deviation and what to do when it happens
AN OVERVIEW OF FIRST-EPISODE PSYCHOSIS PROGRAMS – THE EPINET STUDY (PRESENTER DR. DELBERT ROBINSON)
The treatment of first-episode psychosis has come a long way. Maximizing symptomatic and functional recovery remains one of the main goals. Learn more about the approach of the EPINET study.
EXPLORING NEW TECHNOLOGIES, MEDICATIONS AND THERAPIES – ILLUSTRATING DIFFERENT OPPORTUNITIES FOR PARTICIPATING IN CLINICAL STUDIES AND FINDING THE RIGHT TRIAL FOR YOU (PRESENTER PATRICIA MARCY)
Highlighting aspects and examples of studies with different focus and funding sources to determine what best fits your agency
REFLECTION: HOW HAS RESEARCH BEEN WORKING FOR YOU? THE GOOD, THE BAD AND THE THINGS VRG CAN HELP WITH (PRESENTER PATRICIA MARCY)
Whether you have been engaged in research for years or just dipped your toe in – let us know what works well and where change might be needed.
No pre-registertarion necessary. If you have any questions about participating, please email Marta Hauser at firstname.lastname@example.org